DOCSLIB.ORG

The New York Academy Of

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The New York Academy Of "There needs to be a paradigm shift SPECIAL "Don't shy away from being the from employment, to employability." 2019 GALA INSERT expert you are ... be proud." p5 MISSION POSSIBLE: Closing the Skills Gap p17 THE NEW YORK ACADEMY OF CIENCES SMAGAZINE • FALL 2019 FALL 2019 BOARD OF GOVERNORS 2019-2020 Current as of October 2019 CHAIR Jacqueline Corbelli, Seema Kumar, Vice Lowell Robinson, Corporate Nadav Zafrir, Co-Founder, Paul Stoffels, Vice Chair of Hon. Jerry MacArthur Chairman, CEO and President of Innovation, Director and Advisor; serves Chief Executive Officer, the Executive Committee Hultin, Chair and Co-Founder Co-Founder, BrightLine Global Health and Science as Director of Aratana TEAM8, Inc. and Chief Scientific Officer, of Global Futures Group, LLC Policy Communication for Therapeutics Johnson & Johnson Mikael Dolsten, President, INTERNATIONAL Johnson & Johnson VICE-CHAIR Worldwide Research and Konstantin Shakhnovich, BOARD OF GOVERNORS CHAIRS EMERITI Thomas Pompidou, Founder Development; Senior Vice R. May Lee, Global thought former Goldman Sachs Seth F. Berkley, Chief John E. Sexton, Former Presi- and Partner at Marker, LLC President, Pfizer Inc leadership on innovation, digi- Partner, Head of Systematic Executive Officer, The Global dent, New York University MaryEllen Elia, New York tial transformation, education Market-Making (retired) Alliance for Vaccines and TREASURER Torsten N. Wiesel, Nobel State Commissioner of and gender workplace issues Peter Thorén, Executive Vice Immunization Laura Sachar, Managing Laureate & former Secre- Education and President of Pablo Legorreta, Founder President, Access Industries Partner and Co-Founder, Stefan Catsicas, Chief Tech- tary-General, Human Frontier the University of the State of and CEO, Royalty Pharma StarVest Partners Manuela Veloso, Head of nology Officer Nestlé S.A. Science Program Organiza- New York (USNY) David K.A. Mordecai, Artificial Intelligence Gerald Chan, Co-Founder, tion; President Emeritus, The PRESIDENT Elaine Fuchs, Rebecca C. Co-Managing Member, Research, J.P. Morgan Morningside Group Rockefeller University Ellis Rubinstein, President Lancefield Professor in Numerati‰ Partners, LLC, Grace Wang, Senior Vice Nancy Zimpher, Chancellor and CEO, New York Alice P. Gast, President, Mammalian Cell Biology and RiskEcon‰ Lab for Decision Chancellor for Research and Emeritus, The State Universi- Academy of Sciences Imperial College, London Development, The Rockefel- Metrics, Courant Institute Economic Development ty of New York (SUNY) S. “Kris” Gopalakrishnan, SECRETARY ler University; Investigator, for Mathematical Sciences for the State University Chairman, Axilor Ventures/ HONORARY Larry Smith, New York Howard Hughes Medical NYU, and Co-Founder, Risk of New York (SUNY) and Co-founder Infosys LIFE GOVERNORS Academy of Sciences Institute Economics, Inc. Interim President for SUNY Karen E. Burke, Dermatolo- Paul Horn, Former SV Gregory A. Petsko, Polytechnic Institute Toni Hoover, Director Strat- GOVERNORS egy Planning and Manage- gist and Research Scientist Provost for Research, NYU, Professor of Neurology at Michael W. Young, Nobel Sylvia Acevedo, CEO, Girl ment and COO for the Global John F. Niblack, Former Senior Vice Dean for Strage- Weill Cornell Medicine in Laureate, Richard and Jeanne Scouts of the USA Health Program, The Bill and President, Pfizer Global gic Initiatives and Entrepre- New York City, and Tauber Fisher Professor/Vice Pres- Melinda Gates Foundation Research & Development Ellen de Brabander, Senior neurship; NYU Polytechnic Professor of Biochemistry ident for Academic Affairs, Vice President Research School of Engineering and Chemistry, Emeritus, The Rockefeller University Johan Rockström, Executive and Development Global at Brandeis University in Director of the Stockholm Functions, Governance & Waltham, Massachusetts Resilience Centre, Chairman Compliance, PepsiCo of the EAT Advisory Board PRESIDENT’S COUNCIL Current as of October 2019 Contents Peter Agre, Nobel Laureate; Steven Chu, Nobel Laureate; Co-founder Infosys Ferid Murad, Nobel Laureate; linska Inst.; Former Chairman, Rainer Weiss, Nobel Univ. Prof. and Director, William R. Kenan, Jr. Prof. of Glenda Greenwald, Presi- Director, IMM Center for Cell The Nobel Foundation Laureate; Professor of Executive Editor Editorial Office COVER STORY: HELP WANTED THE NEW YORK ACADEMY OF Johns Hopkins Malaria Physics, Prof. of Molecular dent, Aspen Brain Institute Signaling, The University Ismail Serageldin, Emeritus Physics, Emeritus, Marie Gentile 7 World Trade STEM SKILLS PREFERRED SCIENCES TALENT SHOWCASE Research Inst., Dept. and Cellular Physiology, of Texas at Houston Massachusetts Institute David Gross, Nobel Librarian of the Bibliotheca Molecular Microbiology and Stanford University; Former of Technology Center Laureate; Chancellor’s Chair John F. Niblack, Former Alexandrina and member of Immunology, Bloomberg U.S. Secretary of Energy Copy Editors 250 Greenwich St, 4 HELP WANTED TO CLOSE 19 CELEBRATING THE LAUREATES Professor of Theoretical President, Pfizer Global the Board of Trustees of the George Whitesides, School of Public Health Robert Birchard Aaron J. Ciechanover, Nobel Physics, Kavli Institute for Research and Development; Library of Alexandria Woodford L. and Ann A. 40th Fl THE SKILLS GAP OF THE 2019 BLAVATNIK Richard Axel, Nobel Laureate; Distinguished Re- Theoretical Physics, UCSB Honorary Life Governor, The Phillip A. Sharp, Nobel Flowers University Professor, Mandy Carr New York, NY The need for STEM skills remains NATIONAL AWARDS Laureate; University search Professor, Tumor and New York Academy Harvard University William A. Haseltine, Chair- Laureate; Director, The 10007-2157 Professor, Columbia Univ.; Vascular Biology Research of Sciences central to the national conversation FOR YOUNG SCIENTISTS man and President, ACCESS McGovern Institute, MIT Torsten N. Wiesel, Nobel Investigator, HHMI Center, Faculty of Medicine, Design Health International, Inc. Paul Nurse, Nobel Laureate; Center for Cancer Research Laureate; Chairman Emeritus, P: 212.298.8645 about workforce readiness. David Baltimore, Nobel Technion-Israel Inst. of Tech., Former President, The The New York Academy of Strong Studio Hon. Jerry MacArthur K. Barry Sharpless, Nobel F: 212.298.3655 22 COLLABORATION IS KEY Laureate; President Emeritus, Haifa, Israel Rockefeller University; Former Sciences; Former Secretary Matthew Strong Hultin, Chair and Co-Founder Laureate; The Sharpless 7 MINDING THE SCIENCE AND Caltech Kenneth L. Davis, President President, The Royal Society, General, Human Frontier TO BREAKING NEW GROUND of Global Futures Group, LLC Lab, The Scripps Research Kate Padula Email: magazine@ Etienne-Emile Baulieu, and CEO of the Mount London; Chief Executive, Institute, La Jolla, CA Science Program Organiza- TECHNOLOGY SKILLS GAP IN GENOMICS Louis J. Ignarro, Nobel Laure- Jamie Allaire nyas.org Former President, French Sinai Health System in The Francis Crick Institute tion; President Emeritus, The Corporate leaders, academics ate; Member, Brain Research Feike Sijbesma, CEO/Chair- Academy of Sciences New York City Yoshinori Ohsumi, Nobel Rockefeller University Institute, UCLA; Professor man of the Managing Board, Membership & and policy experts warn of Peter Doherty, Nobel Laureate; Professor, Institute Frank Wilczek, Nobel Contributors 23 HIGH SCHOOL STUDENTS Paul Berg, Nobel Laureate; Emeritus, Molecular & Medi- Royal DSM Laureate; Researcher, St. Jude of Innovative Research, Tokyo Laureate; Herman Feshbach Robert Birchard Annals Orders a widening skills gap. Professor Emeritus, Dept. cal Pharmacology, UCLA Paul Stoffels, Chief INSPIRED TO HELP AFTER of Biochemistry, Stanford Children's Research Hospital, Institute of Technology (IIR) Professor of Physics, P: 212.298.8640 Eric Kandel, Nobel Laureate; Scientific Officer, Johnson Chenelle Bonavito EXPERIENCING NATURAL University Memphis, Tennessee; Univ. John O’Keefe, Nobel Laure- Massachusetts Institute of Prof., Physiology and Cell and Johnson; member of F: 212.298.3650 10 THERE ARE WOMEN IN of Melbourne, Australia ate; Wellcome Trust Principal Technology Martinez DISASTER Len Blavatnik, Founder and Biology, Columbia University the Johnson and Johnson SCIENCE, THE CHALLENGE Chairman, Access Industries Mikael Dolsten, President, Research Fellow and Prof. Executive Committee and Ernst-Ludwig Winnacker, Email: Mehmood Khan, Chief Douglas Braaten and Blavatnik Family Worldwide Research and of Cognitive Neuroscience, Management Committee; Secretary General, Human customerservice@ IS KEEPING THEM THERE Executive Officer, Life Foundation Development; Senior Sainsbury Wellcome Centre, Worldwide Co-Chairman, Frontier Science Program Or- Mandy Carr nyas.org Vice-President, Pfizer Inc Biosciences, Inc.; Former University College London ganization; Former Secretary Gender equality in science has Irina Bokova, Former Director Pharmaceuticals Group Vice Chairman and Chief General, European Research Ann Delfaro become a crisis of retention. PROFESSIONAL DEVELOPMENT General, United Nations Edu- Jan Eliasson, Former Deputy Venkatraman Ramakrishnan, Jack W. Szostak, Nobel Lau- Scientific Officer Council; Former President, cational, Scientific and Cultur- Secretary-General to the Nobel Laureate; President, reate; Investigator, Howard Advertising of Global Research and Deutsche Forschungs- Sonya Dougal 24 INNOVATION CHALLENGES: al Organization (UNESCO) United Nations The Royal Society Hughes Medical Institute; Inquiries Development, PepsiCo gemeinschaft, Germany 12
Load more

Recommended publications
  • The Honorable Francis Collins the Honorable Anthony S. Fauci
    The Honorable Francis Collins The Honorable Anthony S. Fauci Director Director National Institutes of Health National Institute of Allergy and Infectious Diseases Building 1 5601 Fishers Ln 9000 Rockville Pike Rockville, MD 20852 Bethesda, MD 20892 August 25, 2020 Dear Director Collins and Director Fauci, I want to first thank you for your tireless work to ensure that we win the fight against COVID-19. This insidious virus is not only a public health crisis, but also a crisis that is having devastating consequences on our economy. Due to the urgent nature of this pandemic, it is vitally important that we develop effective treatments and vaccines to minimize the virus’ impact and ultimately eradicate it. While I am encouraged about the progress of vaccine development for COVID-19, including the Moderna vaccine which has entered phase 3 trials, I am concerned that those living in underserved communities, especially communities of color, will not be able to easily participate in these trials. I strongly urge you to consider an additional site in Los Angeles closer to and more accessible for my demographically diverse constituents – representing populations that are desperately needed to participate in these trials. The COVID-19 crisis affects all of us, but it is the latest disease to infect and kill communities of color at higher rates than people in the rest of the population. When conducting clinical trials for treatments and vaccines for COVID-19, there needs to be an emphasis to ensure that those who are participating in the trials are racially diverse, so that there are not any disparities in terms of the effectiveness of the treatment.
    [Show full text]
  • Nobel Laureates Endorse Joe Biden
    Nobel Laureates endorse Joe Biden 81 American Nobel Laureates in Physics, Chemistry, and Medicine have signed this letter to express their support for former Vice President Joe Biden in the 2020 election for President of the United States. At no time in our nation’s history has there been a greater need for our leaders to appreciate the value of science in formulating public policy. During his long record of public service, Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaboration in research, and his respect for the contribution that immigrants make to the intellectual life of our country. As American citizens and as scientists, we wholeheartedly endorse Joe Biden for President. Name Category Prize Year Peter Agre Chemistry 2003 Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018 Paul Berg Chemistry 1980 Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008 Elias James Corey Chemistry 1990 Joachim Frank Chemistry 2017 Walter Gilbert Chemistry 1980 John B. Goodenough Chemistry 2019 Alan Heeger Chemistry 2000 Dudley R. Herschbach Chemistry 1986 Roald Hoffmann Chemistry 1981 Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006 Robert J. Lefkowitz Chemistry 2012 Roderick MacKinnon Chemistry 2003 Paul L. Modrich Chemistry 2015 William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995 Richard R. Schrock Chemistry 2005 K. Barry Sharpless Chemistry 2001 Sir James Fraser Stoddart Chemistry 2016 M. Stanley Whittingham Chemistry 2019 James P. Allison Medicine 2018 Richard Axel Medicine 2004 David Baltimore Medicine 1975 J. Michael Bishop Medicine 1989 Elizabeth H. Blackburn Medicine 2009 Michael S.
    [Show full text]
  • Proposed National Center for Advancing Translational Sciences Working Group
    FINAL - September 21, 2011 National Institutes of Health Advisory Committee to the Director Proposed National Center for Advancing Translational Sciences Working Group SUMMARY OF FINDINGS Members: Maria Freire (chair), Julian Adams, Lee Babiss, Brook Byers, William Chin, Susan Desmond-Hellmann, David Ginsburg, Victoria Hale, Helen Hobbs, Robert Langer, Stelios Papadopoulos, Mary Pendergast, Moncef Slaoui, Marc Tessier-Lavigne, David Valle (full titles and affiliations can be found in Appendix A) Dr. Francis Collins convened a Working Group of the Advisory Committee to the NIH Director (ACD) to help identify innovative research areas and activities whereby the proposed National Center for Advancing Translational Sciences (pNCATS) can substantially contribute to catalyze, invigorate and streamline translational sciences nationally and globally (the full charge to the Working Group can be found in Appendix B). The Working Group met four times over the course of nine months. Its first meeting, on February 4, 2011, was held with members of the NIH Institute and Center Directors Working Group on pNCATS in Bethesda, Maryland. The Working Group also met via teleconference on May 24, 2011, and September 14, 2011, and held an in-person meeting in San Francisco, California, on July 15, 2011, where the group hosted two panel sessions to consult experts in project management and cross-sector partnerships (a list of participants can be found in Appendix C). The following represents the summary findings of the ACD-pNCATS Working Group over the course of these meetings. Revolutionize the Process of Translation: Goals for NCATS The creation of NCATS affords NIH a historic opportunity to catalyze, enable, and implement ground-breaking advances in translational sciences – innovations that will benefit all invested in improving human health.
    [Show full text]
  • Ripples in Spacetime
    editorial Ripples in spacetime The 2017 Nobel prize in Physics has been awarded to Rainer Weiss, Barry C. Barish and Kip S. Thorne “for decisive contributions to the LIGO detector and the observation of gravitational waves”. It is, frankly, difficult to find something original to say about the detection of gravitational waves that hasn’t been said already. The technological feat of measuring fluctuations in the fabric of spacetime less than one-thousandth the width of an atomic nucleus is quite simply astonishing. The scientific achievement represented by the confirmation of a century-old prediction by Albert Einstein is unique. And the collaborative effort that made the discovery possible — the Laser Interferometer Gravitational-Wave Observatory (LIGO) — is inspiring. Adapted from Phys. Rev. Lett. 116, 061102 (2016), under Creative Commons Licence. Rainer Weiss and Kip Thorne were, along with the late Ronald Drever, founders of the project that eventually became known Barry Barish, who was the director Last month we received a spectacular as LIGO. In the 1960s, Thorne, a black hole of LIGO from 1997 to 2005, is widely demonstration that talk of a new era expert, had come to believe that his objects of credited with transforming it into a ‘big of gravitational astronomy was no interest should be detectable as gravitational physics’ collaboration, and providing the exaggeration. Cued by detections at LIGO waves. Separately, and inspired by previous organizational structure required to ensure and Virgo, an interferometer based in Pisa, proposals, Weiss came up with the first it worked. Of course, the passion, skill and Italy, more than 70 teams of researchers calculations detailing how an interferometer dedication of the thousand or so scientists working at different telescopes around could be used to detect them in 1972.
    [Show full text]
  • The Committee of Prominent Health Researchers and Nobel Laureates
    PRESS RELEASE New York, NY, June 14, 2018 FOR IMMEDIATE RELEASE Committee of prominent health researchers and Nobel laureates renames the Prix Galien Pro Bono Humanum Award to recognize the global health leadership of Dr. Roy Vagelos was also the first recipient of the original Pro Bono Humanum Award, established in 2007 under the sponsorship of the late Foundation Honorary President and 1986 Nobel Peace Prize recipient, Pr. Elie Wiesel. That first award cited Dr. Vagelos for his unprecedented decision as CEO of a major global pharmaceutical company to donate the drug Mectizan to patients in 34 countries The Prix Galien USA Committee announced today to treat and prevent river blindness (onchocerciasis), that the Prix Galien Pro Bono Humanum Award a parasitic disease that ranks as a leading cause for individual service to improve the state of of preventable blindness in developing countries, human health will be renamed in honor of for “as much and as long as necessary.” Dr. P. Roy Vagelos, Retired Chairman and CEO, Merck & Co., Inc. Chairman of the Board, As result of this historic act of moral leadership, Regeneron Pharmaceuticals. The Roy Vagelos more than two billion treatments for 250 million Pro Bono Humanum Award for Global Health people in affected areas of the globe have been Equity will be presented at the annual Prix Galien donated by Merck & Co. over the past 30 years, USA Awards ceremony recognizing outstanding resulting in the eradication of the parasite in achievement in innovative medicines discovery on numerous countries in Africa and Latin America. Thursday, October 25, at the American Museum of Natural History in New York City.
    [Show full text]
  • Plant Biology 2012…Going Communicating Plant Biology to the Mobile! General Public AAAS Fellows Class of 2011 Life Is About Choices
    ASPB News THE NEWSLETTER OF THE AMERICAN SOCIETY OF PLANT BIOLOGISTS Volume 39, Number 2 March/April 2012 President’s Letter Inside This Issue Walk the Talk to Spread the Word Plant Biology 2012…Going Communicating Plant Biology to the Mobile! General Public AAAS Fellows Class of 2011 Life is about choices. plant biology is at the grocery store, where there’s TAB Articles Now Indexed on PubMed Resources (for most always a rich diversity of safe and relatively inex- of us) are limited, and pensive food. So where’s the problem we so urgently Steve Huber Teaching Tools in Plant every day we must each need to fix, one might ask. Changing this public Biology Seeks Freelance make decisions about where and how we spend perception will require innovative platforms and the Science Editors our time, efforts, and money. Likewise, federal and efforts of all ASPB members as “citizen advocates.” state governments face the continual challenge of We not only can help the public recognize there are prioritizing needs, which is especially important in many potential problems and challenges just ahead times of economic downturn when immediate and that require our action now, but also we must do “pressing” problems tend to receive heightened at- continued on page 5 tention and increased resources. One pressing problem many plant scientists wor- ry about is the sustainable production of sufficient Do you have ideas about how we (and sufficiently nutritious) food for a rapidly grow- can use social media to foster ing global population, especially in light of ongoing dialogue with the public? If so, I climate change.
    [Show full text]
  • August 12, 2021 the Honorable Francis Collins, M.D., Ph.D. Director National Institutes of Health 9000 Rockville Pike Rockvil
    August 12, 2021 The Honorable Francis Collins, M.D., Ph.D. Director National Institutes of Health 9000 Rockville Pike Rockville, MD 20892 Dear Director Collins: On May 20, 2021, we sent you a letter requesting information on the National Institutes of Health’s (NIH) 2014 funding pause on gain of function research.1 Your July 29, 2021, response failed to fully address the questions in our letter. Further, NIH’s response to us appears to be nearly identical to your response to another senator’s separate oversight request.2 Your refusal to provide detailed responses that fully address each oversight request is unacceptable. Specifically, the May 20, 2021 letter included 17 requests for documents and information on the 2014 gain of function moratorium.3 Rather than provide detailed responses to each request, NIH only offered a summary about the gain of function research moratorium and its review process for such research.4 Further, NIH claimed that no National Institute of Allergy and Infectious Diseases (NIAID) funding was approved to support gain of function research at the Wuhan lab.5 Yet, your response appeared to suggest that even approved experiments could result in a virus with a gain of function.6 Without any more detailed information, it is unclear whether this has ever occurred. NIH’s lack of response to the May 20 letter shows a complete disregard for congressional oversight and transparency. Congress and the American people have a right to know the complete truth about NIH’s role in funding potentially risky gain of function research. We expect you to specifically address all of our previous information requests and the additional requests below by no later than August 26, 2021: 1 Letter from Ron Johnson, U.S.
    [Show full text]
  • Recent Observations of Gravitational Waves by LIGO and Virgo Detectors
    universe Review Recent Observations of Gravitational Waves by LIGO and Virgo Detectors Andrzej Królak 1,2,* and Paritosh Verma 2 1 Institute of Mathematics, Polish Academy of Sciences, 00-656 Warsaw, Poland 2 National Centre for Nuclear Research, 05-400 Otwock, Poland; [email protected] * Correspondence: [email protected] Abstract: In this paper we present the most recent observations of gravitational waves (GWs) by LIGO and Virgo detectors. We also discuss contributions of the recent Nobel prize winner, Sir Roger Penrose to understanding gravitational radiation and black holes (BHs). We make a short introduction to GW phenomenon in general relativity (GR) and we present main sources of detectable GW signals. We describe the laser interferometric detectors that made the first observations of GWs. We briefly discuss the first direct detection of GW signal that originated from a merger of two BHs and the first detection of GW signal form merger of two neutron stars (NSs). Finally we present in more detail the observations of GW signals made during the first half of the most recent observing run of the LIGO and Virgo projects. Finally we present prospects for future GW observations. Keywords: gravitational waves; black holes; neutron stars; laser interferometers 1. Introduction The first terrestrial direct detection of GWs on 14 September 2015, was a milestone Citation: Kro´lak, A.; Verma, P. discovery, and it opened up an entirely new window to explore the universe. The combined Recent Observations of Gravitational effort of various scientists and engineers worldwide working on the theoretical, experi- Waves by LIGO and Virgo Detectors.
    [Show full text]
  • Long View of the Human Genome Project BOOKS & ARTS
    Vol 466|19 August 2010 BOOKS & ARTS Long view of the Human Genome Project A bold attempt to tell the complicated story behind the human DNA sequence highlights that social change is needed before personalized medicine can take off, finds Jan Witkowski. Drawing the Map of Life: Inside the Human TTY E Genome Project by Victor K. McElheny Basic Books: 2010. 384 pp. $28, £16.99 S. JAFFE/AFP/G S. In 1985, Robert Sinsheimer, then chancellor of the University of California, Santa Cruz, convened a workshop to discuss sequencing the human genome. It was an audacious proposal: the longest genome that had been sequenced at the time was that of the Epstein- Barr virus, at 172,282 base pairs compared with 3 billion in human DNA. Sinsheimer’s initiative failed. Yet the idea gained momentum when, in 1988, James Watson was appointed associate director of the Office of Genome Research, part of the US National Institutes of Health (NIH). Watson declared 1990 the official start of the publicly funded NIH Human Genome Project (HGP). In 1998, Craig Venter and his company Celera Genomics, then in Rockville, Maryland, joined the race. Ten years ago in June, both projects announced a finish-line draw from President Bill Clinton’s White House. Febru- ary 2011 will mark a decade since the draft sequences were published. Genome-project pioneers: (left to right) Eric Lander, Robert Waterston, James Watson and Francis Collins. In Drawing the Map of Life, science jour- nalist and author Victor McElheny relates McElheny traces the various stages of the In 2000, HGP and Celera jointly announced the story of the HGP, from its methods to the HGP and the power struggles it engendered.
    [Show full text]
  • Rainer Weiss, Professor of Physics Emeritus and 2017 Nobel Laureate
    Giving to the Department of Physics by Erin McGrath RAINER WEISS ’55, PHD ’62 Bryce Vickmark Rai Weiss has established a fellowship in the Physics Department because he is eternally grateful to his advisor, the late Jerrold Zacharias, for all that he did for Rai, so he knows firsthand the importance of supporting graduate students. Rainer Weiss, Professor of Physics Emeritus and 2017 Nobel Laureate. Rainer “Rai” Weiss was born in Berlin, Germany in 1932. His father was a physician and his mother was an actress. His family was forced out of Germany by the Nazis since his father was Jewish and a Communist. Rai, his mother and father fled to Prague, Czecho- slovakia. In 1937 a sister was born in Prague. In 1938, after Chamberlain appeased Hitler by effectively giving him Czechoslovakia, the family was able to obtain visas to enter the United States through the Stix Family in St. Louis, who were giving bond to professional Jewish emigrants. When Rai was 21 years-old, he visited Mrs. Stix and thanked her for what she had done for his family. The family immigrated to New York City. Rai’s father had a hard time passing the medi- cal boards because of his inability to answer multiple choice exams. His mother, who Rai says “held the family together,” worked in a number of retail stores. Through the services of an immigrant relief organization Rai received a scholarship to attend the prestigious Columbia Grammar School. At the end of 1945, when Rai was 13 years old, he became fascinated with electronics and music.
    [Show full text]
  • Report 2018/2019 ETH Institute for Theoretical Studies
    Report 2018/2019 ETH Institute for Theoretical Studies ETH-ITS Table of Contents Foreword 5 The ETH Institute for Theoretical Studies 6 History and aims 6 Fellows at the ITS 6 Collaborations 7 Activities 8 Meetings, talks, minicourses 8 The ITS Science Colloquium 10 Programme 2018–2019 11 Fellows’ seminar 12 Programme 2018–2019 12 Awards 13 Fellows’ report 14 Outlook 22 People at the ETH-ITS 24 Director 24 Coordinator 24 Board of Patrons 24 Advisory Committee 24 2013–2017 2017–2019 Fellows 2014–2019 25 Senior Fellows Junior Fellows (with current affiliation of former Junior Fellows) Contact 27 Clausiusstrasse 47, the address of the ETH Institute for Theoretical Studies. 4 Foreword The academic year 2018/2019 was in several ways special for the Institute for Theoretical Studies. Firstly, it experimen- ted a new way of functioning, dedicating a semester to the interdisciplinary subject of «modular forms, periods and scattering amplitudes», hosting over forty physicists and mathematicians, with a school, a workshop and other events involving several young scientists and putting into contact participants with scientists of ETH. Secondly, the Institute was evaluated by an international committee, who was very positively impressed by the achievements of the Institute and gave interesting suggestions for improvement. Thirdly, on a more personal note, this was my last year as the director of the ETH-ITS; the last six years were an intense period in which I had the unique opportunity to meet scientists in a variety of subjects who are shaping their respective disciplines. I thank the donors for making this possible, the Fellows of the Institute for their excellent scientific contributions, the school board of ETH Zurich for their continuous support, the Advisory Committee for its commitment and advice, and Christina Buchmann, who is retiring this year as coordinator, for her invaluable help and competence in running the Institute.
    [Show full text]
  • Signature of Controversy
    I n “In this volume Granville Sewell provides “As the debate over intelligent design grows T delightful and wide-ranging commentary on increasingly heated... it is refreshing to find a HE the origins debate and intelligent design... discussion of the topic that is calm, thoughtful, Sewell provides much needed clarity on topics and far-ranging, with no sense of having to B e ignature f that are too often misunderstood. His discussion advance an agenda or decimate the opposition. G I S o of the commonly confused problem of entropy In this regard, Granville Sewell’s In the NNI is a must read.” Beginning succeeds brilliantly.” Cornelius G. Hunter, Ph.D. William A. Dembski, Ph.D. N author of The Design Inference author of Science’s Blind Spot G ontroversy A N c In this wide-ranging collection of essays on origins, mathematician Granville Sewell looks at the D big bang, the fine-tuning of the laws of physics, and the evolution of life. He concludes that while O there is much in the history of life that seems to suggest natural causes, there is nothing to support THER Responses to critics of signature in the cEll Charles Darwin’s idea that natural selection of random variations can explain major evolutionary E S advances (“easily the dumbest idea ever taken seriously by science,” he calls it). Sewell explains S A Y why evolution is a fundamentally different and much more difficult problem than others solved s ON by science, and why increasing numbers of scientists are now recognizing what has long been I obvious to the layman, that there is no explanation possible without design.
    [Show full text]